Cost-Effectiveness Analysis of Sintilimab Combined with Chemotherapy Versus Chemotherapy Alone as the First-Line Treatment for Advanced Esophageal Cancer

• Автори: Zhuo-Miao Ye (Автор), Zhe Xu (Автор), Fan-Yuan Zeng (Автор), Zi-Qing Tang (Автор), Qin Zhou (Автор)
• Формат: Книга
• Опубліковано: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Background: Esophageal cancer has a poor prognosis and currently ranks sixth in global cancer mortality rates. The ORIENT-15 trial showed sintilimab plus chemotherapy significantly improved survival when compared to chemotherapy alone. This study aimed to evaluate the cost-effectiveness of sintilima...